A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

NCT04844918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Tirzepatide
OTHER: Placebo

Sponsor

Eli Lilly and Company